Itamar Medical Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 10.999 million compared to USD 8.084 million a year ago. Operating loss was USD 2.514 million compared to USD 979,000 a year ago. Net loss was USD 2.759 million compared to USD 1.147 million a year ago. Basic loss per share from continuing operations was USD 0.01. For the nine months, sales was USD 28.262 million compared to USD 21.493 million a year ago. Operating loss was USD 7.689 million compared to USD 4.017 million a year ago. Net loss was USD 7.999 million compared to USD 4.269 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.